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cardiovascular surgery.(5,6,7,8,9,10) More recent retrospective analyses 
of prospectively collected data suggest that around 5.6% of surgical 
procedures are altered on the basis of intra-operative echo-
cardiographic findings and that there are cost-benefit savings 
particularly during combined valve and graft operations.(11,12,13) 
Recently, the roles for peri-operative echocardiography have 
also extended to include intensive care(14,15) and non-cardiac 
surgery.(16,17,18) Although it is complex to scientifically prove the 
benefits of a diagnostic monitor, TOE has been shown to strongly 
influence intra-operative anaesthetic decisions, particularly in 
patients with increased risk factors for haemodynamic instability 
or myocardial ischaemia. In a prospective observational case series 
of 98 patients undergoing abdominal surgery, the judgement of 
the anaesthetists was that TOE led to useful alterations in intra-
operative care such as administration of fluids, vasoactive drugs 
and β blockers. In some patients, use of the pulmonary artery 
catheter was obviated.(19) Similarly, in another case series com-
prising 90 patients undergoing vascular, visceral and chest surgery, 
TOE directed changes in drug (47%) and fluid therapy (24%).(20) 
* University Hospitals of Leicester NHS Trust, Glenfield Hospital, 
Leicester, United Kingdom
# Heart and Lung Centre, Royal Wolverhampton Hospitals NHS Trust, 
West Midlands, United Kingdom
Address for correspondence: 
Dr Justiaan Swanevelder






Justiaan Swanevelder* and Alexander Ng#  AbstrAct
PERI-OPERATIVE  
TOE
IntroductIon                                                              
In 1976 transoesophageal echocardiography (TOE) was introduced 
into clinical practice.(1) Within a decade, its use extended from 
cardiology departments into the cardiac surgical arena. However, 
at that time few probes were available for the operating theatre. 
Indeed in a report from the United States in 1988, only about 50 
TOE probes were accessible for intra-operative use.(2) Furthermore, 
despite its utility for cardiac surgery, it became evident that few 
cardiologists were able to spend long periods in the operating 
theatre. Over time much enthusiasm and expertise for TOE has 
developed amongst cardiac anaesthesiologists, and by 2001, 94% 
of respondents in a survey of the Society of Cardiovascular 
Anaesthesiologists utilised intra-operative echocardiography in their 
routine practice.(3) 
 
Over the past 30 years technology has improved tremendously and 
intra-operative TOE has become an established imaging modality 
and the gold standard intra-operative cardiac monitor and diagnostic 
tool in certain cardiac procedures, e.g. mitral valve repair, congenital 
heart surgery, etc.(4) There is evidence that intra-operative TOE 
provides valuable information which significantly influences clinical 
management and improves patient outcome. Several investigators 
have documented its benefits in critically ill patients and complex 
cardiac surgery and anaesthesia have come a long way 
since the late 1970s when transoesophageal Echocardio-
graphy (toE) was introduced into the peri-operative arena. 
the development of many surgical procedures and the 
reduction in peri-operative morbidity and mortality can be 
directly related to the use of toE. In complicated surgery 
it has the benefit of providing real time interrogation of 
cardiac structures and function that can be reliable and 
repeatable. As with many interventions a full understanding 
of the limitations, possible artefacts and operating environ-
ment is required to benefit patient care. In 1996 an 
American society of Anaesthesiologists/society of cardio-
vascular Anaesthesiologists task Force published guidelines 
on the indications for intra-operative toE. these published 
guidelines have been updated in 2003 and have recently 
been reviewed once again in the usA and Europe. In this 
document we discuss the role of peri-operative toE and its 





















PErFormIng An IntrA-oPErAtIvE toE                     
A Task Force of the American Society of Echocardiography and 
Society of Cardiovascular Anaesthesiologists has developed guide-
lines for performing a comprehensive intra-operative multiplane 
TOE examination based on a series of 20 anatomical cross- 
sectional images.(21) These guidelines promote training in TOE, 
assist assessment of quality and completeness of individual studies, 
and facilitate comparison of studies performed at different centres. 
A very similar set of guidelines was recommended in 2001 by the 
Working Group on Echocardiography of the European Society of 
Cardiology.(22)
Because the oesophagus is in close relationship to the left atrium 
and posterior aspect of the heart, a high frequency (5 MHz) 2-
dimensional (2-D) TOE transducer can provide clear images of 
most cardiac structures. With pulse wave (PWD) and continuous 
wave Doppler (CWD), blood flow velocity and direction of flow 
can be determined. The use of Colour-flow Doppler (CFD) adds to 
the ability to make a qualitative assessment of cardiac function. 
The multiplane facility has increased the possible 2-D views of a 
routine TOE examination, but still requires the examiner to 
mentally reconstruct a 3-dimensional (3-D) interpretation.  
Recent introduction of 3-D TOE has made such reconstruction 
unnecessary, although the 3-D image still depends on the quality 
of acquired 2-D information. The spatial and temporal resolution of 
the new matrix array transoesophageal transducer (Philips, 
Andover, Massachusetts, USA) with more than 3000 piezoelectric 
elements, allows clear 3-D images at acceptable frame rates. A 
single 3-D volume acquisition over three to five cardiac cycles 
allows comprehensive 2-D evaluation in any plane extracted 
from the dataset.(23) It reduces significantly the number of steps 
required to complete a comprehensive examination, thus mini-
mising examination time.(24) However, detailed quantification i.e. off 
line intra-operative geometric analysis using integrated 3-D mitral 
valve and left ventricular quantification software is slightly cumber-
some.(25) Early evidence suggests that real-time 3-D TOE adds 
additional information to the intra-operative comprehensive exami-
nation and decision making process during cardiac surgery.(26) In 
addition, 3-D images facilitate communication between the echo-
cardiographer and other members of the surgical team.(27) It is 
expected that a combined 2-D and 3-D TOE examination will, in 
the foreseeable future, become routine for intra-operative surgical 
guidance.(28) 
Doppler tissue imaging (DTI) is a supplementary modality that 
measures myocardial velocities, strain and strain rates from specific 
myocardial segments. From these data, it is possible to obtain 
quantitative information on regional and global ventricular func- 
tion as well as left ventricular filling pressure.  There is debate on 
the utility of this information in the peri-operative period owing 
to dynamic alterations in myocardial loading conditions and diffi-
culty with obtaining angle independent measurements.(29,30) Unless 
the operator understands and sticks to all the rules of Doppler, 
these data may be misleading and incorrect.
Recently in paediatric practice, a miniature TOE probe enabling 
multiplane 2-D imaging has been introduced (Philips, Andover, 
Massachusetts, USA). The 48-element transducer measures 8.2 x 
7mm in diameter at the tip with a 5.2mm diameter shaft. This 
technology allows diagnostic intra-operative TOE assessment of 
children and neonates as small as 2-2.5kg.(31) 
 
IndIcAtIons And PrActIcE guIdElInEs                
Early experience with the use of peri-operative echocardiography 
was obtained from its application in cardiac anaesthetic practice; 
recently however, its role has extended to include non-cardiac 
surgery and intensive care.(18) In 1996 an American Society of 
Anaesthesiologists/Society of Cardiovascular Anaesthesiologists 
Task Force published guidelines on the indications for intra-operative 
TOE.(32) They divided the indications into three categories based 
on the strength of supporting evidence or expert opinion that 
this tool improves clinical outcome: 
Category I indications are supported by strong evidence 
and expert opinion that TOE is indicated, very useful and 
will improve patient outcome. These category I indications 
encompass the everyday practice of the intra-operative 
anaesthetist-echocardiographer and will be discussed in more 
detail in this review. 
Category II indications are supported by weaker evidence 
and less expert opinion that TOE will make a difference under 
these circumstances. Here it may be useful and make a differ-
ence to outcome. 
Category III indications have little scientific support or expert 
opinion that TOE will improve the outcome for patients with 
these conditions. This is often due to lack of available relevant 
scientific evidence. 
These published guidelines have been updated in 2003(33) and has 
recently been reviewed once again in the USA(34) and Europe (in 





is that the Task Force of the American Society of Anaesthesiologists 
and the Society of Cardiovascular Anaesthesiologists now recom-
mends that “for adult patients without contraindications, TEE 
should be used in all open heart (e.g. valvular procedures) and all 
thoracic aortic surgical procedures, and should be considered in 
CABG surgeries as well”. Application of this new standard is 
dependant on available technology, funding, as well as user 
knowledge and skills.  Categories II and III include most peri-opera-
tive situations in the “cardiac surgical patient”; owing to their 
extensive list, they will not be discussed in this document.
Category I indications
Life-threatening, persistent haemodynamic instability in the acute 
setting is an important indication for TOE. The use of a pulmonary 
artery (PA) catheter in combination with the thermodilution 
technique has been common in such situations.(35) However, there 
is no conclusive evidence to date that using a PA catheter improves 
outcome in critically ill patients.(36) During haemodynamic evaluation 
TOE has proved reliable and comparative with the PA catheter and 
standard thermodilution techniques.(37) It can provide a real time 
and quick analysis of cardiovascular dysfunction and its use prior to 
other forms of invasive monitoring has been suggested.(38) A survey 
has shown that among anaesthesiologists with echocardiography 
training in the USA and Canada, TOE was preferred as monitor to 
the PA catheter in critically ill patients and complex cardiovascular 
surgery.(39) TOE examination may provide information quicker and 
less invasive than the PA catheter and can avoid uncertainty when 
the cause of instability is unclear or resistant to treatment.  It will 
also provide more extensive real time information with regards to 
heart function and structure. However, when data from both a PA 
catheter and TOE are available, they should be viewed as 
complementary.(40) 
Visualisation of left ventricular and right ventricular function, 
interpreting regional wall motion abnormalities and detection of 
global systolic or diastolic dysfunction can assist the trained clinician. 
Real-time echocardiography images of ventricular filling, ejection 
and cardiac structures allows accurate qualitative evaluation of 
cardiac output, and is of great value in acute situations (Figure 1a, 
Figure 1b). Intermittent quantification of cardiac output by TOE 
may be obtained by measuring the Doppler velocity of blood flow 
across a specific valve (e.g. the aortic valve). Studies show that the 
95% level of agreement of measurements of cardiac output esti-
mated by TOE and also by thermodilution is within 1 litre min-1. 
Whilst these measurements are repeatable within observers, there 
may be much interobserver variability.
Ischaemic heart disease is an important cause of peri-operative 
morbidity and mortality. Compared with monitoring of myocardial 
ischaemia by ECG and S-T segment analysis, TOE enables earlier 
identification.(41) Early myocardial ischaemia may be detected by 
visualising loss of normal systolic wall thickening and inward 
motion, in transverse and longitudinal cross-sectional planes in 
the transgastric position.(42,43) Analysis of ventricular segments can 
elucidate the affected coronary arteries. Following diagnosis, 
response to therapy or intervention can be assessed in real time 
by TOE. 
PERI-OPERATIVE TOE
FIgurE 1a: A real-time transgastric short axis view of the left 
ventricle allows accurate qualitative evaluation of ventricular filling 
and function and is of great value in acute situations. This image 
demonstrates a non-compliant left ventricle with severe concentric 
hypertrophy and preserved systolic function. Should  this patient 
become unstable, volume loading and a higher filling pressure will 
be the management of choice.
FIgurE 1b: A real-time transgastric short axis view of a failing 
and dilated left ventricle: Should this patient become unstable, 



















FIgurE 2a: This live 3-D image demonstrates several flail P2 
chordae causing severe prolapse of the middle scallop of the 
posterior mitral valve leaflet.
Mitral valve repair and replacement are now performed earlier 
in disease staging than before.(44) The role of intra-operative TOE 
for these conditions is well established,(33,45) and has significant 
impact upon post-operative outcome.(46,47) 
Owing to the close relationship of the mitral valve to the oesopha-
gus, clear images can be obtained. By using different views and 
scanning modalities including 3-D TOE, specific leaflet morphology 
can be identified and pathology quantified(48) (Figure 2a, Figure 2b, 
Figure 2c). Ventricular dysfunction that has prognostic value may be 
confirmed by TOE.  At the end of surgery, TOE is used to provide 
quality assurance by checking for residual mitral regurgitation and 
paraprosthetic leak.(49) (Figure 3a, Figure 3b)  In addition to having 
detailed anatomical knowledge of the mitral valve, echocardio-
graphers have to appreciate that under general anaesthesia there 
are functional alterations compared with the pre-operative state, 
e.g. the severity of mitral regurgitation may be underestimated in 
the operating theatre because of a reduction in preload.(50,51,52)
Aortic valve repair procedures are usually complex and require 
the echocardiographer to have a good understanding of different 
mechanisms of pathology and possible surgical procedures.(53,54) 
The vast majority of aortic valves suitable for repair are functionally 
regurgitant (AR) rather than stenotic. Although the severity of AR 
is certainly a consideration, identifying its mechanism by TOE 
may help the surgeon to distinguish those valves suitable for repair 
from chronic fixed abnormalities requiring aortic valve replace-
ment (Figure 4). A functional classification of mechanisms of aortic 
regurgitation pathology has been described to assist during AV 
repair procedures.(55) A valve sparing procedure involving resus-
pension of the cusps is often performed in patients with aortic 
dissection without additional leaflet pathology. Understanding the 
different mechanisms of AR in a patient with acute type A aortic 
dissection is essential to guarantee successful surgical outcome(56) 
(Figure 5a, Figure 5b).
The quality of an aortic valve repair procedure can be assessed 
early, during cardiopulmonary bypass soon after the aortic cross 
clamp has been removed. If the repair is unsuccessful, the high 
aortic pressure due to non-pulsatile bypass flow will cause aortic 
valve regurgitation, which can be demonstrated by TOE. Residual 
aortic regurgitation is a poor prognostic indicator of long term 
outcome and in such cases a second bypass run and replacement 
of the valve is indicated.
FIgurE 2b: This reconstruction of the same mitral valve provides 
a graphic image which may assist to quantify the pathology.
FIgurE 2c: After repair of the same mitral valve with several 
artificial chordae to the posterior leaflet, either 2-D or 3-D echo 
can confirm competence in the operating theatre. The artificial 
chordae are clearly visible on this live 3-D image. 
118
Although routine valve replacement is considered a category II 
indication, TOE provides information that can guide modifications 
of anaesthetic and surgical care which lead to improved out-
come.(57) Use of TOE during more complex valve replacement like 
stentless aortic valve or homograft is invaluable and classed as 
category I.(33) These prostheses require surgical experience and 
accurate intra-operative TOE analysis such as precise diameter 
measurements of the aortic root and ascending aorta as well as the 
origin of the coronary ostia.(58,59) Discrepancy between measure-
ments due to dilatation of the ascending aorta may lead to tether-
ing and splaying of the stentless prosthetic leaflets after implanta-
tion, which may result in AR. Considering these variations in 
PERI-OPERATIVE TOE
pathology, the surgeon will then have to replace or remodel the 
sinotubular junction and or part of the ascending aorta.  After AV 
replacement with a homograft or stentless valve immediate post-
bypass TOE is used to evaluate leaflet mobility and coaptation. 
The prosthesis inside the native root will have the appearance of 
a “tube within a tube”, often with a potential space where the 
different layers of sinus of Valsalva wall and prosthesis overlap. 
Any turbulent flow pattern on colour Doppler may indicate valve 
malposition due to imprecise sizing and implantation.  
The Ross procedure involves the replacement of a diseased aortic 
valve, usually in the younger age group, with the patient’s own 
pulmonary autograft.(60) The pulmonary valve is then replaced 
with a cryopreserved homograft. Accurate pre- and post-surgical 
assessment of the aortic and pulmonary anatomy is essential for 
these procedures. Left ventricular contractility and regional wall 
function should be carefully evaluated for any sign of ischaemia, 
because the first septal perforator of the left anterior descending 
coronary artery can be damaged during harvesting of the pulmon-
ary valve. 
Acute dissection of the ascending aorta needs emergency sur- 
gical intervention. TOE can provide real time evaluation of aortic 
pathology in the operating theatre, which may be advantageous 
over the transportation of an unstable patient to potentially remote 
environments such as CT or MRI suites. Acute dissection with aortic 
valve involvement therefore falls in the category I group of indi-
FIgurE 3a: This 3-D zoom image demonstrates prolapse of the 
middle scallop (P2) of the posterior mitral valve leaflet. Severe 
calcification of the posterior annulus is also visible clearly. 
FIgurE 3b: During repair the surgeon commented on the 
extreme calcification of the annulus. After repair with  complete 
ring prosthesis a high velocity paraprosthesis regurgitant jet was 
observed. The arrow points at a residual cleft between P1 and P2 
on the anterolateral side outside the annuloplasty ring.
FIgurE 4: Accurate measurements of the aortic root are 
necessary to guide surgical repair of the aortic valve. In this patient 
the left ventricular outflow tract diameter measures large at 3.2cm, 
while the sinotubular junction is dilated at 6.1cm diameter. This 




















cations. TOE is more sensitive than trans-thoracic echo (TTE) for 
detection of thoracic aortic dissection and has similar sensitivity and 
specificity to CT and MRI imaging.(61) 
Rapid intra-operative assessment of the aorta is necessary to 
successfully guide the surgeon. The ascending and descending 
aorta should be visualised to demonstrate the true lumen, false 
lumen, intimal flap and entry site. TOE can image the ascending 
aorta but is limited due to the anatomical location of the trachea 
and left main stem bronchus, which lies between the oesophagus 
and aortic arch. As only 80% of the ascending aorta may be 
clearly visualised, it is often difficult to examine the proximal 
arch(62) and epi-aortic scanning may be indicated.(63)
In addition to diagnosing the extent of dissection, TOE is valuable 
to assess other complications. Involvement of the aortic valve and 
presence of a pleural or pericardial effusion with a possible tampo-
nade has important prognostic implications (Figure 5a, Figure 5b). 
Impaired ventricular function and wall motion abnormalities can 
be evaluated and haemodynamic performance optimised in the 
unstable patient.  Dissection extending into the coronary arteries 
can be diagnosed with reasonable accuracy because TOE visualises 
approximately 70-88% of the left, and 25-50% of the right coron-
ary artery ostia.(64) TOE is also helpful in the operating theatre 
during cannulation for cardiopulmonary bypass in patients with 
acute Type A dissection. For example, when the transapical ap-
proach is used, real time imaging assists in guiding the cannula 
across the left ventricular outflow tract and aortic valve, and en-
sures correct positioning into the true lumen.(65)
Intra-operative TOE is essential for congenital heart surgery i.e. a 
category I indication.(33, 66, 67,68) Prior to surgery TOE may display 
clearer images than those of transthoracic echocardiography in 
patients with pulmonary disease or chest deformities. Cardiac 
structural abnormalities can be demonstrated and functional 
haemodynamic limitations can be measured.(69) Whether it is an 
anaesthetist or cardiologist, it is important that the physician 
performing intra-operative paediatric TOE examinations is experi-
enced and has a proper understanding of congenital cardiac 
pathology and the intra-operative conditions.(70) 
A complete sequential segmental TOE analysis is recommended, 
similar to the full pre-operative transthoracic assessment in any 
patient with congenital heart disease.(71) Moreover, in patients with 
intra- or extracardiac shunt it may be useful to calculate shunt 
ratio between the pulmonary and systemic circulations.(72) After 
cardiopulmonary bypass, TOE has been shown to provide initial 
quality assurance of the surgery.(73) Recently, there have been 
advances in 3-D TOE for adolescents,(74) as well as multiplane 
technology which can now be applied in children as small as 2kg.(31) 
A realistic problem with TOE in small children is possible probe 
compression of the airway and big vessels, leading to desatura-
tion(75) and haemodynamic compromise.(76)
Hypertrophic cardiomyopathy (HCM) can be diagnosed with TOE 
and also falls in the category I of indications.(77) Abnormal motion 
of the anterior leaflet of the mitral valve onto a hypertrophic 
interventricular septum during late systole leads to a high pressure 
gradient across the left ventricular outflow tract as well as dynamic 
FIgurE 5a: In this patient with a dissection of the ascending 
aorta, the intimal flap dissects down towards the aortic root 
involving the ostium of the right coronary artery. The aortic valve 
is incompetent as demonstrated with colour flow Doppler.
FIgurE 5b: The same dissection demonstrated in 3-D. The 3- 
dimensional extent of the intimal flap can be appreciated.
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mitral regurgitation.(78) If the patient undergoes surgical myo-
mectomy, intra-operative TOE provides information on specific 
location for myomectomy as well as post-surgical integrity of the 
interventricular septum, mitral valve function, and patency of the 
left ventricular outflow tract. 
TOE is an essential tool during surgical intervention for 
endocarditis.(33) It reveals pathology such as vegetations, abscesses 
and degree of extension to perivalvular tissue. Although more 
invasive than transthoracic echocardiography, TOE provides better 
views and has a higher sensitivity for detecting paravalvular abs-
cesses, and vegetations (87-100%) on native and prosthetic 
valves.(79) 
Although the diagnosis of pericardial effusions and use of TOE 
during pericardial surgery falls in category 2, the task force has 
classed it as category 1 in patients with posterior or loculated 
effusions, when TOE is used to evaluate the adequacy of a pericardial 
window procedure.(32,33) In spite of limited scientific evidence, it is 
expert opinion that TOE is beneficial during these procedures if it 
helps to avoid serious haemodynamic complications.(80) 
Placement of intracardiac devices and monitoring of their position 
during port-access and other cardiac surgical interventions are also 
category 1 indications. For example, due to complex interaction of 
RV and LV function, and importance of correct positioning of LV 
assist device cannulae, it has been demonstrated that TOE guidance 
improves cardiac performance during placement of mechanical 
support devices.(81)  
Category II and III indications
It is interesting that according to the 2003 ACC/AHA/ASE guide-
lines, the only category III indication for peri-operative echo-
cardiography is surgical repair of uncomplicated secundum atrial 
septal defect.(33) Under category II falls the rest of the cardiac 
conditions, procedures and interventions when the patient may 
be at risk of ischaemia or haemodynamic instability. The feeling 
among most anaesthetic echocardiographers is that many Cate-
gories II and III indications may well be upgraded to Category I in 
future when more relevant scientific evidence becomes avail-




Complication rates and mortality associated with the use of 
TOE are extremely low. Data for complications attributable to 
PERI-OPERATIVE TOE
TOE are derived from cardiac anaesthetic practice. In a case series 
of 4 784 patients, six complications were detected, giving an 
incidence of 0.13%.(82) This rate is similar to that of another case 
series examining 7200 patients where TOE-associated morbidity 
and mortality was 0.2% and 0% respectively.(83) Typical injuries 
include a sore throat, dental injury, upper gastrointestinal haemor-
rhage and oesophageal perforation. Equipment familiarity and an 
experienced anaesthetic team avoid perhaps one of the most 
important potential complications - the anaesthetist’s attention 
being distracted from patient care. The benefits of peri-operative 
echocardiography should therefore be weighed against the risks 
that it poses.(84) 
 
There are few absolute contra-indications. Recent oesophageal 
surgery, oesophageal strictures, diverticulae and tumours will be 
contra-indications. However, TOE may be used for patients with 
oral, oesophageal or gastric disease, if the expected benefit 
outweighs the potential risk, and provided appropriate precautions 
are taken (e.g. smallest possible probe).(34) Anti-coagulation with 
warfarin or heparin within the therapeutic range can only be 
considered a very relative contra-indication.
trAInIng And quAlIty AssurAncE                         
A substantial level of training is required to obtain maximum bene-
fit from TOE as a high quality peri-operative monitor and diag- 
nostic tool. The development of training and certification in 
echocardiography has been a long and intensive process in Europe 
and the USA. Excellent comprehensive TOE courses have been 
developed,(85) and working groups on TOE have published extensive 
practice and training guidelines on both sides of the Atlantic and in 
Japan.(86, 87) The American Society of Cardiothoracic Anaesthesiolo-
gists (SCA) developed the first formal examination in peri-opera-
tive TOE in 1998.(88) The SCA and American Society of Echo-
cardiography (ASE) then combined forces to establish the National 
Board of Echocardiography, which had the responsibility to further 
administer examinations and develop a certification process in 
clinical echocardiography.(89) 
Europe has followed a similar route with the Association of 
Cardiothoracic Anaesthetists of Great Britain and Ireland (ACTA) 
joining forces with the British Society of Echocardiography (BSE) to 
establish an accreditation process in TOE with its first examination 
held in the UK in 2003.(90) Since then the European Association of 
Cardiothoracic Anaesthesiologists (EACTA) and the European 



















pean TOE examination and accreditation process in 2005.  In 2004, 
the Japanese Society of Cardiovascular Anaesthesiologists launched 
its first TOE competency examination. The purpose of these 
accreditation processes is to enable recognition of special com-
petence in peri-operative echocardiography against an objective 
standard.  All accreditation processes consist of two parts. With the 
practical part the candidate must demonstrate adequate training 
and competency through a supervised residency program or log-
book. The theoretical part requires the successful completion of 
a multiple choice and image clip examination. 
In the case of anaesthetists, traditional TOE training is performed 
in the operating room during a cardiac surgical procedure with 
its time constraints and limitations e.g. electrocautery inter- 
ference. Recently a commercial TOE simulator has been developed 
(Heartworks) which allows the examination of a mannequin with 
a realistic “digital” TOE probe.(91) This simulator greatly simplifies 
teaching of probe manipulations and image acquisition of normal 
anatomy, and has enormous potential for training. Continuous 
improvement of quality of peri-operative echocardiography should 
be pursued not only by individual practitioners, but also by echo-
cardiography departments.(92,93) 
conclusIon                                                                  
Cardiac surgery and anaesthesia have come a long way since the 
late 1970s when TOE was introduced into the peri-operative arena. 
The development of many cardiac surgical procedures and the 
reduction in peri-operative morbidity and mortality can be directly 
related to the use of TOE.(94) 
Furthermore, as our expectations for improved peri-operative 
outcomes continue to rise, we envisage that we will, in future, see 
an increase in the application of TOE for major non-cardiac surgery 
as well as for intensive care. With improvements in training, software, 
miniaturisation of technology and availability of affordable basic 
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